Effectiveness of oral propranolol in a patient with neurofibromatosis type 1 and infantile hemangiomas

Ital J Dermatol Venerol. 2021 Dec;156(Suppl. 1 to No. 6):6-7. doi: 10.23736/S2784-8671.19.06179-0. Epub 2019 Mar 29.

Authors

Emanuele Miraglia¹, Amalia Schiavetti², Giulia Varrasso², Mauro Celli², Stefano Calvieri³, Sandra Giustini³

Affiliations

¹ Department of Dermatology and Venereology, Sapienza University, Rome, Italy - emanuele.miraglia@hotmail.it.
² Department of Pediatrics, Sapienza University, Rome, Italy.
³ Department of Dermatology and Venereology, Sapienza University, Rome, Italy.

PMID: 30924624
DOI: 10.23736/S2784-8671.19.06179-0

No abstract available

MeSH terms

Hemangioma* / complications
Hemangioma, Capillary* / complications
Humans
Infant
Neurofibromatosis 1* / complications
Propranolol / therapeutic use

Substances

Propranolol